X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
humans (22) 22
metabolic syndrome (16) 16
female (15) 15
male (15) 15
middle aged (15) 15
oxidative stress (15) 15
non-alcoholic fatty liver disease (14) 14
adult (11) 11
liver diseases (11) 11
aged (10) 10
fatty liver (10) 10
risk (9) 9
risk factors (9) 9
care and treatment (8) 8
insulin resistance (8) 8
internal medicine (8) 8
atherosclerosis (7) 7
cardiovascular-disease (7) 7
gastroenterology & hepatology (7) 7
insulin-resistance (7) 7
steatohepatitis (7) 7
hepatic steatosis (6) 6
medicine, general & internal (6) 6
analysis (5) 5
biomarkers - blood (5) 5
cardiac & cardiovascular systems (5) 5
cardiovascular (5) 5
cholesterol (5) 5
diagnosis (5) 5
digestive system diseases (5) 5
lipid-peroxidation (5) 5
management (5) 5
medicine & public health (5) 5
non-alcoholic fatty liver disease - complications (5) 5
non-alcoholic fatty liver disease - diagnosis (5) 5
non-alcoholic steatohepatitis (5) 5
risk assessment (5) 5
steatosis (5) 5
ultrasonography (5) 5
biomarkers (4) 4
cardiovascular disease (4) 4
cardiovascular diseases - etiology (4) 4
cross-sectional studies (4) 4
dyslipidemia (4) 4
fatty liver-disease (4) 4
gastroenterology (4) 4
guidelines (4) 4
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (4) 4
liver (4) 4
multivariate analysis (4) 4
non-alcoholic fatty liver disease - diagnostic imaging (4) 4
non-alcoholic fatty liver disease - drug therapy (4) 4
non-alcoholic fatty liver disease - metabolism (4) 4
nutritional and metabolic diseases (4) 4
prevalence (4) 4
severity (4) 4
severity of illness index (4) 4
statins (4) 4
studies (4) 4
article (3) 3
association (3) 3
biopsy (3) 3
cardiovascular risk (3) 3
case-control studies (3) 3
cohort studies (3) 3
deficiency (3) 3
diabetes (3) 3
digestive system (3) 3
disease (3) 3
hypercholesterolemia (3) 3
linear models (3) 3
liver cirrhosis (3) 3
lysosomal acid lipase (3) 3
medicine (3) 3
metabolic disorders (3) 3
metabolic syndrome - complications (3) 3
nadph oxidase 2 (3) 3
non-alcoholic fatty liver disease - epidemiology (3) 3
peripheral vascular disease (3) 3
pnpla3 (3) 3
population (3) 3
research article (3) 3
risk-factors (3) 3
treatment outcome (3) 3
triglycerides (3) 3
3 gene pnpla3 (2) 2
activation (2) 2
aged, 80 and over (2) 2
american association (2) 2
antioxidants (2) 2
antioxidants - therapeutic use (2) 2
antithrombotic therapy (2) 2
atherosclerosis - etiology (2) 2
atorvastatin (2) 2
atrial fibrillation (2) 2
atrial fibrillation - complications (2) 2
biochemistry & molecular biology (2) 2
biology (2) 2
blood pressure (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Gastroenterology, ISSN 0002-9270, 12/2017, Volume 112, Issue 12, pp. 1832 - 1839
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 115, Issue 10, pp. 1402 - 1406
Journal Article
Journal Article
世界胃肠病学杂志:英文版(电子版), ISSN 1007-9327, 2014, Volume 20, Issue 26, pp. 8341 - 8350
Non-alcoholic fatty liver disease(NAFLD)is the most common and emerging form of chronic liver disease worldwide.It includes a wide spectrum of liver diseases... 
disease | Non-alcoholic | fatty | liver | ste | Nonalcoholic | Oxidative stress | Vitamin D | Vitamin E | Pioglitazone | Cardiovascular risk | Insulin resistance | Non-alcoholic fatty liver disease | Non-alcoholic steatohepatitis | Statins | VITAMIN-E | LIPID-PEROXIDATION | OXIDATIVE STRESS PARAMETERS | MEDITERRANEAN DIET | ATHEROGENIC DYSLIPIDEMIA | INSULIN-RESISTANCE | CARDIOVASCULAR-DISEASE | MITOCHONDRIAL DYSFUNCTION | PLACEBO-CONTROLLED TRIAL | GASTROENTEROLOGY & HEPATOLOGY | HEPATIC STEATOSIS | Caloric Restriction | Humans | Exercise | Vitamin D Deficiency - therapy | Obesity - diagnosis | Diabetes Mellitus - diagnosis | Bariatric Surgery | Hypoglycemic Agents - therapeutic use | Risk Assessment | Risk Reduction Behavior | Comorbidity | Risk Factors | Insulin Resistance | Non-alcoholic Fatty Liver Disease - therapy | Obesity - physiopathology | Treatment Outcome | Non-alcoholic Fatty Liver Disease - physiopathology | Antioxidants - therapeutic use | Vitamin D Deficiency - epidemiology | Diabetes Mellitus - physiopathology | Diabetes Mellitus - epidemiology | Diabetes Mellitus - therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Obesity - epidemiology | Non-alcoholic Fatty Liver Disease - diagnosis | Obesity - therapy | Vitamin D - therapeutic use | Non-alcoholic Fatty Liver Disease - epidemiology | Topic Highlight
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 1868 - 1868
  NAFLD was significantly higher in the poor adherence group (88.5% vs 79,0%; p=0.003). [...]MD score was significantly lower in patients with NAFLD compared... 
Cardiovascular | Internal Medicine | Liver diseases | Studies | Diet | Metabolism
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 3702 - 10
NAFLD is a polygenic condition but the individual and cumulative contribution of identified genes remains to be established. To get additional insight into the... 
CONFERS SUSCEPTIBILITY | SUPERFAMILY MEMBER 2 | MBOAT7 | MULTIDISCIPLINARY SCIENCES | PNPLA3 | RISK | STEATOHEPATITIS | VARIANT | SEVERITY | GENOME-WIDE ASSOCIATION | TM6SF2 | Single-nucleotide polymorphism | Liver diseases | Fatty liver | Genotypes
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 04/2014, Volume 14, Issue 1, pp. 81 - 81
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 11/2015, Volume 16, Issue 12, pp. 28014 - 28021
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 01/2017, Volume 83, Issue 1, pp. 88 - 95
Journal Article